Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AVITA Medical (AVHHL) EPS (Weighted Average and Diluted) (2018 - 2025)

AVITA Medical posted quarterly EPS (Weighted Average and Diluted) of -$0.37 for Q4 2025, up 15.91% year-on-year from -$0.32 in Q4 2024, and up 19.57% on a QoQ basis from -$0.46 in Q3 2025.

AVITA Medical (AVHHL) has 8 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.37 in Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 15.91% year-over-year to -$0.37; the trailing twelve-month figure through Dec 2025 stood at -$1.74 (up 27.2% YoY), and the FY2025 full-year result was -$1.74, up 27.2% from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 stood at -$0.37, up from -$0.46 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.38 in Q1 2022 and bottomed at -$0.73 in Q1 2024.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.37 (2023), against an average of -$0.22.
  • The widest annual swing landed in 2021, when EPS (Weighted Average and Diluted) jumped 136.62%; it then plunged 254.55% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.24 in 2021, then declined by 8.33% to $0.22 in 2022, then tumbled by 227.27% to -$0.28 in 2023, then tumbled by 57.14% to -$0.44 in 2024, then increased by 15.91% to -$0.37 in 2025.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$0.37 (Q4 2025), -$0.46 (Q3 2025), and -$0.38 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.61
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.24
10 AVITA Medical - - 14.31 Mn -0.37

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -0.37
Sep 30, 2025 -0.46
Jun 30, 2025 -0.38
Mar 31, 2025 -0.53
Dec 31, 2024 -0.44
Sep 30, 2024 -0.62
Jun 30, 2024 -0.60
Mar 31, 2024 -0.73
Dec 31, 2023 -0.28
Sep 30, 2023 -0.34
Jun 30, 2023 -0.41
Mar 31, 2023 -0.37
Dec 31, 2022 0.22
Sep 30, 2022 0.22
Mar 31, 2022 0.38
Sep 30, 2021 0.24
Jun 30, 2021 0.19
Mar 31, 2021 0.26
Dec 31, 2020 -0.26
Sep 30, 2020 0.48
Jun 30, 2020 -0.60
Mar 31, 2020 -0.71
Dec 31, 2019 -0.53
Sep 30, 2019 -0.19
Jun 30, 2019 -0.41
Mar 31, 2019 -0.34
Dec 31, 2018 -0.44
Sep 30, 2018 -0.38
Jun 30, 2018 -2.07